COVID-19 and Transplant Patients: Challenges, Risks, and Evolving Strategies
Conflicts of Interest
References
- Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.M.; Lau, E.H.Y.; Wong, J.Y.; et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia. N. Engl. J. Med. 2020, 382, 1199. [Google Scholar] [CrossRef]
- Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020, 395, 497, Erratum in Lancet 2020, 395, 496. https://doi.org/10.1016/S0140-6736(20)30252-X. [Google Scholar] [CrossRef]
- WHO Director-General’s Opening Remarks at the Media Briefing on COVID19—March 2020. Available online: www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---27-july-2020 (accessed on 27 February 2025).
- World Health Organization. Coronavirus Disease 2019 (COVID-19): Situation Report—38. 27 February 2020. Available online: www.who.int/docs/default-source/coronaviruse/situation-reports/20200227-sitrep-38-covid-19 (accessed on 27 February 2025).
- Cancarevic, I.; Nassar, M.; Daoud, A.; Ali, H.; Nso, N.; Sanchez, A.; Parikh, A.; Ul Hosna, A.; Devanabanda, B.; Ahmed, N.; et al. Mortality rate of COVID-19 infection in end stage kidney disease patients on maintenance hemodialysis: A systematic review and meta-analysis. World J. Virol. 2022, 11, 352. [Google Scholar] [CrossRef]
- Campise, M.; Alfieri, C.M.; Perego, M.; Tamborini, F.; Cresseri, D.; Gandolfo, M.T.; Binda, V.; Regalia, A.; Messa, P. COVID-19 Infection in Kidney Transplant Patients: An Italian One Year Single Centre Experience. Pathogens 2021, 10, 964. [Google Scholar] [CrossRef]
- Messika, J.; Eloy, P.; Roux, A.; Hirschi, S.; Nieves, A.; Le Pavec, J.; Sénéchal, A.; Saint Raymond, C.; Carlier, N.; Demant, X.; et al. French Group of Lung Transplantation. COVID-19 in Lung Transplant Recipients. Transplantation 2021, 105, 177. [Google Scholar] [CrossRef]
- Hardgrave, H.; Wells, A.; Nigh, J.; Klutts, G.; Krinock, D.; Osborn, T.; Bhusal, S.; Rude, M.K.; Burdine, L.; Giorgakis, E. COVID-19 Mortality in Vaccinated vs. Unvaccinated Liver & Kidney Transplant Recipients: A Single-Center United States Propensity Score Matching Study on Historical Data. Vaccines 2022, 10, 1921. [Google Scholar] [CrossRef]
- Yuan, Y.; Jiao, B.; Qu, L.; Yang, D.; Liu, R. The development of COVID-19 treatment. Front. Immunol. 2023, 14, 1125246. [Google Scholar] [CrossRef]
- Prasad, V.; Haslam, A. COVID-19 vaccines: History of the pandemic’s great scientific success and flawed policy implementation. Monash Bioeth. Rev. 2024, 42, 28–54. [Google Scholar] [CrossRef]
- Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, C.B.; et al. Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med. 2021, 384, 403. [Google Scholar] [CrossRef]
- Chen, X.; Luo, D.; Mei, B.; Du, J.; Liu, X.; Xie, H.; Liu, L.; Su, S.; Mai, G. Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: A systematic review and meta-analysis. Clin. Microbiol. Infect. 2023, 29, 441–456. [Google Scholar] [CrossRef]
- Barda, N.; Dagan, N.; Cohen, C.; Hernán, M.A.; Lipsitch, M.; Kohane, I.S.; Reis, B.Y.; Balicer, R.D. Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: An observational study. Lancet 2021, 398, 2093. [Google Scholar] [CrossRef]
- Collier, A.Y.; Yu, J.; McMahan, K.; Liu, J.; Chandrashekar, A.; Maron, J.S.; Atyeo, C.; Martinez, D.R.; Ansel, J.L.; Aguayo, R.; et al. Differential Kinetics of Immune Responses Elicited by COVID-19 Vaccines. N. Engl. J. Med. 2021, 385, 2010–2012. [Google Scholar] [CrossRef]
- Wang, Q.; Guo, Y.; Bowen, A.; Mellis, I.A.; Valdez, R.; Gherasim, C.; Gordon, A.; Liu, L.; Ho, D.D. XBB.1.5 monovalent mRNA vaccine booster elicits robust neutralizing antibodies against XBB subvariants and JN.1. Cell Host Microbe 2024, 32, 315–321.e3. [Google Scholar] [CrossRef]
- Baghani, M.; Fathalizade, F.; Loghman, A.H.; Samieefar, N.; Ghobadinezhad, F.; Rashedi, R.; Baghsheikhi, H.; Sodeifian, F.; Rahimzadegan, M.; Akhlaghdoust, M. COVID-19 vaccine hesitancy worldwide and its associated factors: A systematic review and meta-analysis. Sci. One Health 2023, 2, 100048. [Google Scholar] [CrossRef]
- Gavi, the Vaccine Alliance. COVAX Explained. 2023. Available online: https://www.gavi.org/vaccineswork/covax-explained (accessed on 27 February 2025).
- World Health Organization. COVID-19 Vaccinations Shift to Regular Immunization as COVAX Draws to a Close. 2023. Available online: https://www.who.int/news/item/19-12-2023-covid-19-vaccinations-shift-to-regular-immunization-as-covax-draws-to-a-close (accessed on 27 February 2025).
- Omboni, S.; Padwal, R.S.; Alessa, T.; Benczúr, B.; Green, B.B.; Hubbard, I.; Kario, K.; Khan, N.A.; Konradi, A.; Logan, A.G.; et al. The worldwide impact of telemedicine during COVID-19: Current evidence and recommendations for the future. Connect. Health Telemed. 2022, 1, 7–35. [Google Scholar] [CrossRef]
- Gawande, M.S.; Zade, N.; Kumar, P.; Gundewar, S.; Weerarathna, I.N.; Verma, P. The role of artificial intelligence in pandemic responses: From epidemiological modeling to vaccine development. Mol. Biomed. 2025, 6, 1. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Campise, M. COVID-19 and Transplant Patients: Challenges, Risks, and Evolving Strategies. Vaccines 2025, 13, 318. https://doi.org/10.3390/vaccines13030318
Campise M. COVID-19 and Transplant Patients: Challenges, Risks, and Evolving Strategies. Vaccines. 2025; 13(3):318. https://doi.org/10.3390/vaccines13030318
Chicago/Turabian StyleCampise, Mariarosaria. 2025. "COVID-19 and Transplant Patients: Challenges, Risks, and Evolving Strategies" Vaccines 13, no. 3: 318. https://doi.org/10.3390/vaccines13030318
APA StyleCampise, M. (2025). COVID-19 and Transplant Patients: Challenges, Risks, and Evolving Strategies. Vaccines, 13(3), 318. https://doi.org/10.3390/vaccines13030318